Related Experiment Video
Updated: Mar 21, 2026

04:54
Author Spotlight: Standardizing and Improving the Extraction and Purification of Extracellular Vesicles from Human ADSCs
Published on: May 3, 2024
1.3K
In vitro characterization and angiogenic potential of quality-and-quantity mononuclear cell-derived extracellular
Suttipong Tianwattanatada1, Nuttapol Chruewkamlow2, Narinee Srimark3
1Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Jvs-Vascular Science
|March 20, 2026
Summary
Quality-and-quantity culture mononuclear cells-derived extracellular vesicles (QQMNC-EVs) show promising angiogenic properties and high production rates. These extracellular vesicles (EVs) demonstrate potential as a novel therapeutic strategy for chronic limb ischemia.
Area of Science:
- Cell Biology
- Biotechnology
- Regenerative Medicine
Background:
- Extracellular vesicles (EVs) are emerging as key mediators in cell-to-cell communication.
- Understanding the angiogenic potential of EVs derived from specific cell sources is crucial for therapeutic development.
Purpose of the Study:
- To evaluate the presence, production rate, and in vitro angiogenic properties of quality-and-quantity culture mononuclear cells-derived extracellular vesicles (QQMNC-EVs).
Main Methods:
- Peripheral blood mononuclear cells (PBMNCs) were cultured to generate QQMNCs.
- EVs were isolated from QQMNCs, PBMNCs, CD34+ cells, and late endothelial progenitor cells (EPCs).
- EV characterization involved nanoparticle tracking analysis, flow cytometry, western blot, and electron microscopy; angiogenic potential was assessed via tube formation assays.
Main Results:
- QQMNC-EVs were successfully identified and met established EV criteria.
- QQMNCs exhibited the highest EV production rate compared to other cell types.
- QQMNC-EVs demonstrated dose-dependent in vitro angiogenic efficacy, comparable to CD34+-EVs and late EPC-EVs at low concentrations and superior at high concentrations.
Conclusions:
- QQMNC-EVs possess significant in vitro angiogenic properties and high production rates.
- These findings suggest QQMNC-EVs hold potential as a novel therapeutic strategy for conditions like chronic limb-threatening ischemia.
Keywords:
AngiogenesisExtracellular vesiclesPeripheral blood mononuclear cellsProduction rateQuality-and-quantity culture media
